Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3044)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$590.99
Total Value
$413.69K
Shares Held After
325,123
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$589.98
Total Value
$591.75K
Shares Held After
325,823
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,597
Price
$588.95
Total Value
$940.55K
Shares Held After
326,826
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$587.88
Total Value
$776.00K
Shares Held After
328,423
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$586.93
Total Value
$831.67K
Shares Held After
329,743
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
470
Price
$585.72
Total Value
$275.29K
Shares Held After
331,160
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$584.83
Total Value
$828.70K
Shares Held After
331,630
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
807
Price
$583.94
Total Value
$471.24K
Shares Held After
333,047
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
89
Price
$582.66
Total Value
$51.86K
Shares Held After
333,854
% of Holdings
0.0%
VERACYTE, INC. (VCYT)
Holstein Jens — Director
Shares
7,500
Price
$50.00
Total Value
$375.00K
Shares Held After
27,471
% of Holdings
21.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
14,850
Price
$50.00
Total Value
$742.57K
Shares Held After
10,247
% of Holdings
59.2%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,553
Price
$5.10
Total Value
$18.10K
Shares Held After
733,270
% of Holdings
0.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
2,310
Price
$186.99
Total Value
$431.95K
Shares Held After
39,765
% of Holdings
5.5%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,581
Price
$43.19
Total Value
$68.28K
Shares Held After
164,028
% of Holdings
1.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
7,866
Price
$37.69
Total Value
$296.47K
Shares Held After
54,645
% of Holdings
12.6%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$43.19
Total Value
$29.71K
Shares Held After
177,269
% of Holdings
0.4%
XBiotech Inc. (XBIT)
SIMARD JOHN — Director
Shares
368,524
Price
$1.93
Total Value
$711.25K
Shares Held After
4,191,690
% of Holdings
8.8%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
97,982
Price
$41.59
Total Value
$4.08M
Shares Held After
723,020
% of Holdings
13.6%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
48,988
Price
$41.59
Total Value
$2.04M
Shares Held After
6,380,517
% of Holdings
0.8%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,672
Price
$5.03
Total Value
$8.42K
Shares Held After
729,717
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
806
Price
$592.92
Total Value
$477.89K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
694
Price
$591.60
Total Value
$410.57K
Shares Held After
325,249
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$590.57
Total Value
$401.59K
Shares Held After
325,943
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$589.64
Total Value
$754.74K
Shares Held After
326,623
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$588.47
Total Value
$730.29K
Shares Held After
327,903
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,707
Price
$587.54
Total Value
$1.59M
Shares Held After
329,144
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,492
Price
$586.54
Total Value
$875.12K
Shares Held After
331,851
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$585.71
Total Value
$351.43K
Shares Held After
333,343
% of Holdings
0.2%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
25,124
Price
$11.75
Total Value
$295.09K
Shares Held After
1,624,789
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,378
Price
$26.30
Total Value
$88.84K
Shares Held After
377,802
% of Holdings
0.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
8,503
Price
$25.94
Total Value
$220.57K
Shares Held After
381,180
% of Holdings
2.2%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
66,411
Price
$1.77
Total Value
$117.41K
Shares Held After
3,036,411
% of Holdings
2.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,606
Price
$2.38
Total Value
$22.86K
Shares Held After
3,011,749
% of Holdings
0.3%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
1,000
Price
$41.82
Total Value
$41.82K
Shares Held After
625,038
% of Holdings
0.2%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
500
Price
$41.82
Total Value
$20.91K
Shares Held After
6,331,529
% of Holdings
0.0%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
94,000
Price
$41.31
Total Value
$3.88M
Shares Held After
624,038
% of Holdings
15.1%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
47,000
Price
$41.31
Total Value
$1.94M
Shares Held After
6,331,029
% of Holdings
0.7%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,626
Price
$4.83
Total Value
$27.17K
Shares Held After
728,045
% of Holdings
0.8%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
25,520
Price
$3.53
Total Value
$90.13K
Shares Held After
670,917
% of Holdings
3.7%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
7,669
Price
$3.55
Total Value
$27.24K
Shares Held After
696,437
% of Holdings
1.1%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
4,767
Price
$3.56
Total Value
$16.99K
Shares Held After
286,673
% of Holdings
1.6%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
9,591
Price
$3.58
Total Value
$34.38K
Shares Held After
2,038,894
% of Holdings
0.5%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
14,000
Price
$3.55
Total Value
$49.65K
Shares Held After
542,375
% of Holdings
2.5%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
4
Price
$1.32
Total Value
$5.28
Shares Held After
956,584
% of Holdings
0.0%
Pluri Inc. (PLUR)
Manieu Alexandre Weinstein — Director
Shares
833,334
Price
$1.50
Total Value
$1.25M
Shares Held After
2,083,334
% of Holdings
40.0%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
2,510
Price
$12.11
Total Value
$30.39K
Shares Held After
1,599,665
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
7,381
Price
$25.28
Total Value
$186.59K
Shares Held After
377,802
% of Holdings
1.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
4,500
Price
$24.50
Total Value
$110.25K
Shares Held After
385,183
% of Holdings
1.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
6,234
Price
$2.38
Total Value
$14.84K
Shares Held After
3,002,143
% of Holdings
0.2%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
8,000
Price
$2.98
Total Value
$23.84K
Shares Held After
1,054,003
% of Holdings
0.8%
3044 transactions